Literature DB >> 16501204

Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery.

C Berry, D Kingsmore, S Gibson, D Hole, J J Morton, D Byrne, H J Dargie.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16501204      PMCID： PMC1860808          DOI： 10.1136/hrt.2005.060988

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

2.  Coronary-artery revascularization before elective major vascular surgery.

Authors:  Edward O McFalls; Herbert B Ward; Thomas E Moritz; Steven Goldman; William C Krupski; Fred Littooy; Gordon Pierpont; Steve Santilli; Joseph Rapp; Brack Hattler; Kendrick Shunk; Connie Jaenicke; Lizy Thottapurathu; Nancy Ellis; Domenic J Reda; William G Henderson
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

3.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

4.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

5.  Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.

Authors:  K A Eagle; C M Coley; J B Newell; D C Brewster; R C Darling; H W Strauss; T E Guiney; C A Boucher
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391
  5 in total
  6 in total

1.  Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery.

Authors:  Paolo Mercantini; Salvatore Di Somma; Laura Magrini; Andrea Kazemi Nava; Andrea Scarinci; Marco La Torre; Mario Ferri; Enrico Ferri; Niccolò Petrucciani; Vincenzo Ziparo
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 2.  B-type peptides to predict post-liver transplant mortality: systematic review and meta-analysis.

Authors:  Daljeet Chahal; Alan Yau; Paola Casciato; Vladimir Marquez
Journal:  Can Liver J       Date:  2019-02-25

3.  Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study.

Authors:  Samuel S Gidding; Fida Bacha; Petter Bjornstad; Lorraine E Levitt Katz; Lynne L Levitsky; Jane Lynch; Jeanie B Tryggestad; Ruth S Weinstock; Laure El Ghormli; Joao A C Lima
Journal:  J Pediatr       Date:  2018-01       Impact factor: 4.406

4.  NT-proBNP: A Useful Biochemical Marker for Prognosis in Rh-Isoimmunized Pregnancies.

Authors:  Vikas Yadav; Dipika Deka; Sharma Aparna; Vatsla Dadhwal
Journal:  J Obstet Gynaecol India       Date:  2018-10-01

5.  Postoperative B-type natriuretic Peptide levels associated with prolonged hospitalization in hypertensive patients after non-cardiac surgery.

Authors:  Jae Hong Park; Gil Ja Shin; Jae In Ryu; Wook Bum Pyun
Journal:  Korean Circ J       Date:  2012-08-31       Impact factor: 3.243

6.  Elevated BNP caused by recombinant human interleukin-11 treatment in patients with chemotherapy-induced thrombocytopenia.

Authors:  Na-Wei Liu; Xin Huang; Shuang Liu; Wen-Jian Liu; Hua Wang; Wei-da Wang; Yue Lu
Journal:  Support Care Cancer       Date:  2019-03-15       Impact factor: 3.603
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.